From Casetext: Smarter Legal Research

Lewis v. Sutherland

United States District Court, W.D. Pennsylvania
Jun 5, 2024
C. A. 24-43 Erie (W.D. Pa. Jun. 5, 2024)

Opinion

C. A. 24-43 Erie

06-05-2024

SYLVESTER LEWIS, Plaintiff, v. MARK SUTHERLAND, et al., Defendants.


Richard Lanzillo, Chief Magistrate Judge

MEMORANDUM ORDER

SUSAN PARADISE BAXTER, United States District Judge

Plaintiff Sylvester Lewis, an inmate incarcerated at the State Correctional Facility at Forest in Marienville, Pennsylvania, commenced this pro se civil rights action in the Court of Common Pleas of Forest County, Pennsylvania. The action was removed to this Court by Notice of Removal filed on February 15, 2024 [ECF No. 1], and was referred to Chief United States Magistrate Judge Richard A. Lanzillo for report and recommendation in accordance with the Magistrates Act, 28 U.S.C. § 636(b)(1), and Rules 72.1.3 and 72.1.4 of the Local Rules for Magistrates.

Plaintiff generally asserts that several medical providers and prison officials at SCI-Forest were deliberately indifferent to his serious medical needs because they disregarded his complaints of skipped heartbeats and arrythmia and prescribed medications that were either ineffective or made things worse. Among the Defendants named in the complaint are four prescription medications: Zantac, Prilosec, Alvesco, and Atelenol.

On May 1, 2024, Judge Lanzillo issued a report and recommendation (“R&R”) recommending that Plaintiffs claims against Defendants Zantac, Prilosec, Alvesco, and Atelenol be dismissed as legally frivolous in accordance with 28 U.S.C. § 1915(e), because they are not “persons” subject to suit under 42 U.S.C. § 1983, nor can they act under color of state law [ECF No. 11]. Timely objections to the R&R have been filed by Plaintiff [ECF No. 18]; however, they do nothing more than restate Plaintiffs allegations.

After de novo review of the complaint, together with the report and recommendation and objections thereto, the following order is entered:

AND NOW, this 5th day of June, 2024;

IT IS HEREBY ORDERED that the report and recommendation of Chief Magistrate Judge Lanzillo, issued May 1, 2024 [ECF No. 11], is adopted as the opinion of the Court, and Plaintiffs claims against Defendants Zantac, Prilosec, Alvesco, and Atelenol are DISMISSED as frivolous pursuant to 28 U.S.C. § 1915(e). The Clerk is directed to terminate said Defendants from this case.


Summaries of

Lewis v. Sutherland

United States District Court, W.D. Pennsylvania
Jun 5, 2024
C. A. 24-43 Erie (W.D. Pa. Jun. 5, 2024)
Case details for

Lewis v. Sutherland

Case Details

Full title:SYLVESTER LEWIS, Plaintiff, v. MARK SUTHERLAND, et al., Defendants.

Court:United States District Court, W.D. Pennsylvania

Date published: Jun 5, 2024

Citations

C. A. 24-43 Erie (W.D. Pa. Jun. 5, 2024)